114 related articles for article (PubMed ID: 15013843)
1. Discovery of novel peptide/receptor interactions: identification of PHM-27 as a potent agonist of the human calcitonin receptor.
Ma JN; Currier EA; Essex A; Feddock M; Spalding TA; Nash NR; Brann MR; Burstein ES
Biochem Pharmacol; 2004 Apr; 67(7):1279-84. PubMed ID: 15013843
[TBL] [Abstract][Full Text] [Related]
2. Use of constitutive G protein-coupled receptor activity for drug discovery.
Chen G; Way J; Armour S; Watson C; Queen K; Jayawickreme CK; Chen WJ; Kenakin T
Mol Pharmacol; 2000 Jan; 57(1):125-34. PubMed ID: 10617687
[TBL] [Abstract][Full Text] [Related]
3. Divergent structural requirements exist for calcitonin receptor binding specificity and adenylate cyclase activation.
Houssami S; Findlay DM; Brady CL; Martin TJ; Epand RM; Moore EE; Murayama E; Tamura T; Orlowski RC; Sexton PM
Mol Pharmacol; 1995 Apr; 47(4):798-809. PubMed ID: 7723741
[TBL] [Abstract][Full Text] [Related]
4. A human orphan calcitonin receptor-like structure.
Flühmann B; Muff R; Hunziker W; Fischer JA; Born W
Biochem Biophys Res Commun; 1995 Jan; 206(1):341-7. PubMed ID: 7818539
[TBL] [Abstract][Full Text] [Related]
5. Agonist-dependent consequences of proline to alanine substitution in the transmembrane helices of the calcitonin receptor.
Bailey RJ; Hay DL
Br J Pharmacol; 2007 Jul; 151(5):678-87. PubMed ID: 17486143
[TBL] [Abstract][Full Text] [Related]
6. Cloning and characterization of an abundant subtype of the human calcitonin receptor.
Kuestner RE; Elrod RD; Grant FJ; Hagen FS; Kuijper JL; Matthewes SL; O'Hara PJ; Sheppard PO; Stroop SD; Thompson DL
Mol Pharmacol; 1994 Aug; 46(2):246-55. PubMed ID: 8078488
[TBL] [Abstract][Full Text] [Related]
7. Possible endogenous agonist mechanism for the activation of secretin family G protein-coupled receptors.
Dong M; Pinon DI; Asmann YW; Miller LJ
Mol Pharmacol; 2006 Jul; 70(1):206-13. PubMed ID: 16531505
[TBL] [Abstract][Full Text] [Related]
8. Amylin receptor phenotypes derived from human calcitonin receptor/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment.
Tilakaratne N; Christopoulos G; Zumpe ET; Foord SM; Sexton PM
J Pharmacol Exp Ther; 2000 Jul; 294(1):61-72. PubMed ID: 10871296
[TBL] [Abstract][Full Text] [Related]
9. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
[TBL] [Abstract][Full Text] [Related]
10. Newly-identified receptors for peptide histidine-isoleucine and GHRH-like peptide in zebrafish help to elucidate the mammalian secretin superfamily.
Wu S; Roch GJ; Cervini LA; Rivier JE; Sherwood NM
J Mol Endocrinol; 2008 Nov; 41(5):343-66. PubMed ID: 18757498
[TBL] [Abstract][Full Text] [Related]
11. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
[TBL] [Abstract][Full Text] [Related]
12. Side-chain lactam-bridge conformational constraints differentiate the activities of salmon and human calcitonins and reveal a new design concept for potent calcitonin analogues.
Taylor JW; Jin QK; Sbacchi M; Wang L; Belfiore P; Garnier M; Kazantzis A; Kapurniotu A; Zaratin PF; Scheideler MA
J Med Chem; 2002 Feb; 45(5):1108-21. PubMed ID: 11855991
[TBL] [Abstract][Full Text] [Related]
13. Receptor pharmacology.
Young A
Adv Pharmacol; 2005; 52():47-65. PubMed ID: 16492540
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and utility of novel benzophenone-containing calcitonin analogs for photoaffinity labeling the calcitonin receptor.
Suva LJ; Flannery MS; Caulfield MP; Findlay DM; Jüppner H; Goldring SR; Rosenblatt M; Chorev M
J Pharmacol Exp Ther; 1997 Nov; 283(2):876-84. PubMed ID: 9353409
[TBL] [Abstract][Full Text] [Related]
15. Glycosylation is important for binding to human calcitonin receptors.
Ho HH; Gilbert MT; Nussenzveig DR; Gershengorn MC
Biochemistry; 1999 Feb; 38(6):1866-72. PubMed ID: 10026267
[TBL] [Abstract][Full Text] [Related]
16. Human H9 cells proliferation is differently controlled by vasoactive intestinal peptide or peptide histidine methionine: implication of a GTP-insensitive form of VPAC1 receptor.
Goursaud S; Pineau N; Becq-Giraudon L; Gressens P; Muller JM; Janet T
J Neuroimmunol; 2005 Jan; 158(1-2):94-105. PubMed ID: 15589042
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the structural and functional properties of cloned calcitonin receptor cDNAs.
Goldring SR; Gorn AH; Yamin M; Krane SM; Wang JT
Horm Metab Res; 1993 Sep; 25(9):477-80. PubMed ID: 8225201
[TBL] [Abstract][Full Text] [Related]
18. Relaxin-3, INSL5, and their receptors.
Liu C; Lovenberg TW
Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
[TBL] [Abstract][Full Text] [Related]
19. Desensitization and re-sensitization of CGRP receptor function in human neuroblastoma SK-N-MC cells.
Pin SS; Xu C; Bahr BA
Eur J Pharmacol; 2007 Dec; 577(1-3):7-16. PubMed ID: 17825280
[TBL] [Abstract][Full Text] [Related]
20. Deletions of genes encoding calcitonin/alpha-CGRP, amylin and calcitonin receptor have given new and unexpected insights into the function of calcitonin receptors and calcitonin receptor-like receptors in bone.
Lerner UH
J Musculoskelet Neuronal Interact; 2006; 6(1):87-95. PubMed ID: 16675892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
